首页 › 基金 › Cercano Management LLC › DNLI
Cercano Management LLC 对 DNLI 的持仓历史
DENALI THERAPEUTICS INC · 医疗保健
Cercano Management LLC 在 Q3 2026 的 13F 申报中披露持有 DNLI(DENALI THERAPEUTICS INC)625,000 股,市值约 US$12.9M,约占其申报组合的 1.77%,在其申报持仓中市值排名第 7 位。 Cercano Management LLC 最近 13 个申报季度中有 13 个季度披露了 DNLI 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Cercano Management LLC 对 DNLI 的持仓演变
Cercano Management LLC 于 Q3 2023 首次披露 DNLI 持仓:625,000 股(约 US$12.9M)。 该持仓在 Q3 2024 达到峰值 625,000 股,市值约 US$18.2M。 在 13 次申报中,Cercano Management LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 625,000 股、市值约 US$12.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 625.00K | $12.89M | 新进 |
| Q4 2023 | 625.00K | $13.41M | 持有 |
| Q1 2024 | 625.00K | $12.82M | 持有 |
| Q2 2024 | 625.00K | $14.51M | 持有 |
| Q3 2024 | 625.00K | $18.21M | 持有 |
| Q4 2024 | 625.00K | $12.74M | 持有 |
| Q1 2025 | 625.00K | $8.50M | 持有 |
| Q2 2025 | 625.00K | $8.74M | 持有 |
| Q3 2025 | 625.00K | $9.07M | 持有 |
| Q4 2025 | 625.00K | $10.32M | 持有 |
| Q1 2026 | 625.00K | $12.00M | 持有 |
| Q2 2026 | 625.00K | $16.07M | 持有 |
| Q3 2026 | 625.00K | $12.92M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DNLI 与 13F 数据
DNLI(DENALI THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 DNLI,申报仓位最大的包括:淡马锡控股 (US$180.4M), Temasek Holdings (Private) Ltd (US$145.0M), BAKER BROS. ADVISORS LP (US$96.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DNLI 的基金
- 淡马锡控股 7.01M 股 · $180.37M · Q2 2026
- Temasek Holdings (Private) Ltd 7.01M 股 · $144.96M · Q3 2026
- BAKER BROS. ADVISORS LP 3.73M 股 · $96.05M · Q2 2026
- Casdin 资本 2.04M 股 · $52.60M · Q2 2026
- Crestline Management, L.P. 1.91M 股 · $49.14M · Q2 2026
- Foresite Capital Management VI LLC 1.40M 股 · $35.92M · Q2 2026
- Siren, L.L.C. 1.40M 股 · $28.87M · Q3 2026
- ADAR1 Capital Management, LLC 1.03M 股 · $26.47M · Q2 2026
更多关于 Cercano Management LLC
常见问题
How long has Cercano Management LLC held DNLI?
Cercano Management LLC has disclosed DNLI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Cercano Management LLC's current position in DNLI?
As of Q3 2026, Cercano Management LLC holds 625.00K shares of DNLI (DENALI THERAPEUTICS INC), valued at $12.92M, representing 1.77% of its reported portfolio and ranking #7.
Has Cercano Management LLC been buying or selling DNLI?
In the latest 13F filing (Q3 2026), Cercano Management LLC held unchanged its position in DNLI. The position peaked in Q3 2024 at 625.00K shares.
Which other funds hold DNLI?
Other major institutional holders of DNLI include 淡马锡控股, Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.